Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
暂无分享,去创建一个
B. Dijkmans | M. Visser | W. Lems | G. Nijpels | J. Dekker | R. Heine | M. Boers | C. Stehouwer | M. Nurmohamed | Y. Smulders | A. Voskuyl | V. V. van Halm | M. Peters | V. P. van Halm
[1] B. Cronstein,et al. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. , 2008, Arthritis and rheumatism.
[2] B. Dijkmans,et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation , 2008, Annals of the rheumatic diseases.
[3] Y. Shoenfeld,et al. Tobacco smoking and autoimmune rheumatic diseases , 2007, Nature Clinical Practice Rheumatology.
[4] T. Therneau,et al. The widening mortality gap between rheumatoid arthritis patients and the general population. , 2007, Arthritis and rheumatism.
[5] E. Pérez-Pampín,et al. All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists , 2007, Annals of the rheumatic diseases.
[6] B. Dijkmans,et al. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study , 2006, Arthritis research & therapy.
[7] Yasmin,et al. Rheumatoid Arthritis Is Associated With Increased Aortic Pulse-Wave Velocity, Which Is Reduced by Anti–Tumor Necrosis Factor-&agr; Therapy , 2006, Circulation.
[8] A. Silman,et al. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. , 2005, Arthritis and rheumatism.
[9] M. González-Gay,et al. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.
[10] C. Turesson,et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.
[11] J. Schwartz,et al. Arterial Stiffness in Chronic Inflammatory Diseases , 2005, Hypertension.
[12] B. Joffe,et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. , 2005, The Journal of rheumatology.
[13] S. Gabriel,et al. Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.
[14] S. Gabriel,et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. , 2005, Arthritis and rheumatism.
[15] C. Cooper,et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study , 2004, Heart.
[16] C. Turesson,et al. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study , 2004, Annals of the rheumatic diseases.
[17] B. Dijkmans,et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.
[18] M. Bots,et al. [Trends in cardiovascular morbidity and mortality in the Netherlands, 1980-2000]. , 2004, Nederlands tijdschrift voor geneeskunde.
[19] L. Bouter,et al. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. , 2003, European heart journal.
[20] D. O'leary,et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. , 2003, Arthritis and rheumatism.
[21] H. Tunstall-Pedoe,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.
[22] J. Cockcroft,et al. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis , 2003, Annals of the rheumatic diseases.
[23] J. Manson,et al. Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis , 2003, Circulation.
[24] J. Robins,et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study , 2002, The Lancet.
[25] G. McColl,et al. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? , 2002, Arthritis and rheumatism.
[26] G L Freeman,et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.
[27] S. Houterman,et al. Trends in total and high density lipoprotein cholesterol and their determinants in The Netherlands between 1993 and 1997. , 2001, International journal of epidemiology.
[28] A. T. N. Group,et al. Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes. , 2001, Diabetologia.
[29] S. Rantapää-Dahlqvist,et al. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. , 1999, The Journal of rheumatology.
[30] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[31] C. Helmick,et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. , 1998, Arthritis and rheumatism.
[32] S. R. Dahlqvist,et al. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. , 1997, The Journal of rheumatology.
[33] H. Valkenburg,et al. Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study , 1995, Diabetes Care.
[34] F. Wolfe,et al. The mortality of rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[35] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[36] W. Kannel,et al. Cardiac failure and sudden death in the Framingham Study. , 1988, American heart journal.
[37] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[38] S. Gabriel,et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. , 2003, Arthritis and rheumatism.
[39] M. Prevoo,et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[40] H. Holman,et al. Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.